2‐Substituted 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity

A series of 6‐(hetero)aryl‐ or 6‐methyl‐7‐deazapurine ribonucleosides bearing a substituent at position 2 (Cl, F, NH2, or CH3) were prepared by cross‐coupling reactions at position 6 and functional group transformations at position 2. Cytostatic, antiviral, and antimicrobial activity assays were performed. The title compounds were observed to be potent and selective inhibitors of Mycobacterium tuberculosis adenosine kinase (ADK), but not human ADK; moreover, they were found to be non‐cytotoxic. The antimycobacterial activities against M. tuberculosis, however, were only moderate. The reason for this could be due to either poor uptake through the cell wall or to parallel biosynthesis of adenosine monophosphate by the salvage pathway.

[1]  Helena Zábranská,et al.  Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides. , 2014, Journal of medicinal chemistry.

[2]  Michal Hocek,et al.  Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides. , 2014, Journal of medicinal chemistry.

[3]  I. Pichová,et al.  6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents , 2013 .

[4]  Michal Hocek,et al.  Synthesis and Cytostatic and Antiviral Activities of 2′‐Deoxy‐2′,2′‐difluororibo‐ and 2′‐Deoxy‐2′‐fluororibonucleosides Derived from 7‐(Het)aryl‐7‐deazaadenines , 2013, ChemMedChem.

[5]  Michal Hocek,et al.  Synthesis of 2′-deoxy-2′-fluororibo- and 2′-deoxy-2′,2′-difluororibonucleosides derived from 6-(het)aryl-7-deazapurines , 2012 .

[6]  R. Pohl,et al.  Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides. , 2012, Bioorganic & medicinal chemistry.

[7]  S. Juršėnas,et al.  Synthesis of 4-aryl-, 2,4-diaryl- and 2,4,7-triarylpyrrolo[2,3-d]pyrimidines by a combination of the Suzuki cross-coupling and N-arylation reactions , 2012 .

[8]  I. Pichová,et al.  Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines. , 2011, Journal of medicinal chemistry.

[9]  C. Cameron,et al.  Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. , 2010, Journal of medicinal chemistry.

[10]  Helena Zábranská,et al.  CycloSal‐phosphate Pronucleotides of Cytostatic 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Cytostatic Activity, and Inhibition of Adenosine Kinases , 2010, ChemMedChem.

[11]  R. Pohl,et al.  6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents. , 2010, Journal of medicinal chemistry.

[12]  C. K. Chu,et al.  Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase. , 2008, Journal of medicinal chemistry.

[13]  J. Sacchettini,et al.  High Resolution Crystal Structures of Mycobacterium tuberculosis Adenosine Kinase , 2007, Journal of Biological Chemistry.

[14]  W. Parker,et al.  Purine metabolism in Mycobacterium tuberculosis as a target for drug development. , 2007, Current pharmaceutical design.

[15]  W. Parker,et al.  Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety. , 2006, Biochemical pharmacology.

[16]  M. Erion,et al.  Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues. , 2005, Journal of Medicinal Chemistry.

[17]  M. Otto,et al.  Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides. , 2005, Journal of medicinal chemistry.

[18]  R. Pohl,et al.  Highly Methylated Purines and Purinium Salts as Analogues of Heteromines , 2005 .

[19]  B. Ugarkar,et al.  Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition. , 2005, Journal of medicinal chemistry.

[20]  P. D. Cook,et al.  Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. , 2004, Journal of medicinal chemistry.

[21]  M. Erion,et al.  Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides. , 2003, Journal of medicinal chemistry.

[22]  P. Gannett,et al.  Efficient one-step Suzuki arylation of unprotected halonucleosides, using water-soluble palladium catalysts. , 2003, The Journal of organic chemistry.

[23]  Michal Hocek,et al.  An efficient synthesis of 2-substituted 6-methylpurine bases and nucleosides by Fe- or Pd-catalyzed cross-coupling reactions of 2,6-dichloropurines. , 2003, The Journal of organic chemistry.

[24]  Z. Janeba,et al.  Efficient syntheses of 2-chloro-2'-deoxyadenosine (cladribine) from 2'-deoxyguanosine(1). , 2003, The Journal of organic chemistry.

[25]  Z. Janeba,et al.  Nucleic acid related compounds. 116. Nonaqueous diazotization of aminopurine nucleosides. Mechanistic considerations and efficient procedures with tert-butyl nitrite or sodium nitrite. , 2002, The Journal of organic chemistry.

[26]  M. Erion,et al.  Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. , 2000, Journal of medicinal chemistry.

[27]  J. Montgomery,et al.  Convenient Syntheses of 6-Methylpurine and Related Nucleosides , 2000, Nucleosides, nucleotides & nucleic acids.

[28]  Michal Hocek,et al.  Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids. , 2000, Journal of medicinal chemistry.

[29]  G. Gillespie,et al.  Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. , 1998, Biochemical pharmacology.

[30]  Yukio,et al.  Convenient Method for the Synthesis of C-Alkylated Purine Nucleosides : Palladium-Catalyzed Cross-Coupling Reaction of Halogenopurine Nucleosides with Trialkylaluminums. , 1992 .

[31]  T. Soulimane,et al.  2,4‐Disubstituted Pyrrolo[2,3‐d]pyrimidine α‐D‐ and β‐D‐Ribofuranosides Related to 7‐Deazaguanosine , 1990 .

[32]  F. Seela,et al.  Stereoselective synthesis of pyrrolo[2,3‐d]pyrimidine α‐ and β‐D‐ribonucleosides from anomerically pure D‐ribofuranosyl chlorides: Solid‐Liquid Phase‐Transfer Glycosylation and 15N‐NMR Spectra , 1988 .

[33]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[34]  R. West,et al.  2-Alkyl(aryl)- and 2,7-Dimethyl-4-substituted Aminopyrrolo [2,3-d] pyrimidines , 1961 .

[35]  A. Villela,et al.  Pyrimidine salvage pathway in Mycobacterium tuberculosis. , 2011, Current medicinal chemistry.

[36]  R. Pohl,et al.  Phosphoramidate pronucleotides of cytostatic 6-aryl-7-deazapurine ribonucleosides. , 2011, Bioorganic & medicinal chemistry.

[37]  Michal Hocek,et al.  CYTOSTATIC 6-ARYLPURINE NUCLEOSIDES IV + . SYNTHESIS OF 2-SUBSTITUTED 6-PHENYLPURINE RIBONUCLEOSIDES , 2002 .

[38]  Michal Hocek,et al.  Cytostatic 6-Arylpurine Nucleosides III. Synthesis and Structure-Activity Relationship Study in Cytostatic Activity of 6-Aryl-, 6-Hetaryl- and 6-Benzylpurine Ribonucleosides , 2001 .

[39]  R. M. Otoski,et al.  Stereoselective preparations of ribofuranosyl chlorides and ribofuranosyl acetates.Solvent effects and stereoselectivity in the reaction of ribofuranosyl acetates with trimethylallylsilane , 1986 .